Utrecht University: Pharmaceutical scientists conduct a wide range of research on corona vaccines

On January 6, a health care employee in Veghel was the first to receive a corona vaccination in the Netherlands. Approximately 15 million more will follow – perhaps even this year. Pharmaceutical scientists of Utrecht University conduct research on the coronavaccine from different angles. From the effectiveness to the safety of the vaccines. And from the roll out of the vaccination programme to a fair international distribution.

“We want to ensure that coronavirus vaccines can be stored at room temperature”

Enrico Mastrobattista conducts research into nanoparticles that can improve the effectiveness and storage of vaccines. The nanoparticles are an essential component of coronavirus vaccines, but they also make it more difficult to distribute the pharmaceuticals because they are generally only stable at low temperatures. Read the full article.

More on Enrico Mastrobattista

“We monitor the safety and effectiveness of coronavirus vaccines internationally”
Olaf Klungel
Olaf Klungel studies the safety and effectiveness of pharmaceuticals. He has been involved in research into the side effects of coronavirus vaccines since last year. Olaf Klungel focuses on the methods used: “All sorts of coronavirus research is currently being done around the world. Speed is of the essence at the moment, but the research should still be done properly.” Read the full article.

More on Olaf Klungel

“Pharmacists can play a role in coronavirus vaccinations”
Marcel Bouvy
The vaccination programme that will be rolled out in the Netherlands this year to vaccinate anyone who wishes against Covid-19 presents a major organisational challenge. According to Professor of Pharmaceutical Patient Care Marcel Bouvy, pharmacists could be of assistance in that effort. Bouvy also studies care for former coronavirus patients. Read the full article.

More on Marcel Bouvy

“We have to distribute the coronavirus vaccines fairly around the world”

Aukje Mantel-Teeuwisse’s research into global access to medication also applies to the distribution of the coronavirus vaccines. “We have to show solidarity with low- and middle-income countries.” Read the full article.